RGEN
RGEN
NASDAQ · Life Sciences Tools & Services

Repligen Corp

$116.30
-0.05 (-0.04%)
Day Range $113.66 — $117.74
52W Range $102.97 — $175.77

Performance

1D
1W
1M
3M -30.03%
6M -7.41%
1Y -18.07%
YTD -29.24%
Open$114.79
Previous Close$116.35
Day High$117.74
Day Low$113.66
52W High$175.77
52W Low$102.97
Volume
Avg Volume1.03M
Market Cap6.43B
P/E Ratio131.56
EPS$0.86
SectorLife Sciences Tools & Services

Technical Indicators

Full analysis →
SMA 50 $157.63 Below
SMA 200 $139.06 Below
RSI (14) 28 Oversold
Trend Golden Cross Bullish

Analyst Ratings

Strong Buy
28 analysts
23 Buy 5 Hold 0 Sell
Price Target -46.6% upside
Current
$116.30
Target
$62.10
$40.44 $62.10 avg $74.58

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 737.26M 757.72M 4.59B
Net Income 48.83M 45.16M 325.04M
Profit Margin 6.6% 6.3% 7.1%
EBITDA 136.54M 133.31M 499.02M
Free Cash Flow 285.62M
Rev Growth -2.7% -2.7% +1.3%
Debt/Equity 0.26 0.26 0.50

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $490.29 +2.55% 26.1 175.01B
DHR Danaher Corp $190.10 +0.05% 37.1 133.90B
A Agilent Technologies Inc $114.20 +1.95% 24.4 31.51B
IQV Iqvia Holdings Inc $166.09 -0.52% 20.8 28.25B
MTD Mettler-Toledo International $1,264.46 +2.05% 29.5 25.63B
WAT Waters Corp $301.92 +0.04% 28.1 18.02B

RGEN News

No news for RGEN yet

Quick Stats

Market Cap6.43B
P/E Ratio131.56
EPS$0.86
Volume
SectorLife Sciences Tools & Services